These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6699881)

  • 1. Studies of the mode of action of antitumor triazenes and triazines. 6. 1-Aryl-3-(hydroxymethyl)-3-methyltriazenes: synthesis, chemistry, and antitumor properties.
    Vaughan K; Tang Y; Llanos G; Horton JK; Simmonds RJ; Hickman JA; Stevens MF
    J Med Chem; 1984 Mar; 27(3):357-63. PubMed ID: 6699881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor inhibitory triazenes. 3. Dealkylation within an homologous series and its relation to antitumor activity.
    Wilman DE; Cox PJ; Goddard PM; Hart LI; Merai K; Newell DR
    J Med Chem; 1984 Jul; 27(7):870-4. PubMed ID: 6737430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and cytotoxic effects of hydroxymethyl-3-pyridyl- and 2-chloro-5-pyridyltriazene derivatives.
    Grancharov KC; Koch M; Volm M; Kolar GF
    Cancer Lett; 1988 Aug; 41(3):271-9. PubMed ID: 3409206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triazene drug metabolites: part 15. Synthesis and plasma hydrolysis of anticancer triazenes containing amino acid carriers.
    Carvalho E; Iley J; Perry MJ; Rosa E
    Pharm Res; 1998 Jun; 15(6):931-5. PubMed ID: 9647361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and antitumor activity of 1-aryl-3,3-dimethyltriazene derivatives.
    Giraldi T; Nisi C; Connors TA; Goddard PM
    J Med Chem; 1977 Jun; 20(6):850-3. PubMed ID: 874961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure/activity investigations in eight arylalkyltriazenes comparison of chemical stability, mode of decomposition, and SCE induction in Chinese hamster V79-E cells.
    Thust R; Schneider M; Wagner U; Schreiber D
    Cell Biol Toxicol; 1991 Apr; 7(2):145-65. PubMed ID: 1889006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactions of substituted arenediazonium chlorides with methylamine-formaldehyde premix revisited: reactivity and transformations of methylolamine intermediates and their biological significance.
    Kolar GF; Schendzielorz M
    Z Naturforsch C J Biosci; 1987; 42(1-2):41-6. PubMed ID: 2953132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The geometry of N-hydroxymethyl compounds. Part 2: Crystal structures of 1-(4-carbethoxyphenyl)-3-hydroxymethyl-3-methyltriazene, N-hydroxymethylpentamethylmelamine and N-hydroxymethylbenzamide.
    Simmonds RJ; Katenga EB; Schwalbe CH
    Anticancer Drug Des; 1988 Aug; 3(2):91-101. PubMed ID: 3136779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the mode of action of antitumour triazenes and triazines--IV. The metabolism of 1-(4-acetylphenyl)-3,3-dimethyltriazene.
    Farina P; Gescher A; Hickman JA; Horton JK; D'Incalci M; Ross D; Stevens MF; Torti L
    Biochem Pharmacol; 1982 May; 31(10):1887-92. PubMed ID: 7104021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, physicochemical properties, and antitumor activities of analogs of 1-phenyl-3-benzyl-3-methyltriazenes.
    Dunn WJ; Greenberg MJ
    J Pharm Sci; 1977 Oct; 66(10):1416-9. PubMed ID: 21950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor inhibitory triazenes. 2. Variation of antitumor activity within an homologous series.
    Wilman DE; Goddard PM
    J Med Chem; 1980 Sep; 23(9):1052-4. PubMed ID: 7411549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor activity of methyltriazene prodrugs simultaneously releasing DNA-methylating agents and the antiresistance drug O(6)-benzylguanine.
    Wanner MJ; Koch M; Koomen GJ
    J Med Chem; 2004 Dec; 47(27):6875-83. PubMed ID: 15615536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogenicity of cytostatic triazenes.
    Kolar GF
    IARC Sci Publ; 1986; (78):111-26. PubMed ID: 3583385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triazene drug metabolites. Part 17: Synthesis and plasma hydrolysis of acyloxymethyl carbamate derivatives of antitumour triazenes.
    Carvalho E; Francisco AP; Iley J; Rosa E
    Bioorg Med Chem; 2000 Jul; 8(7):1719-25. PubMed ID: 10976519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional-group modifications of dextran for linkage to a diazonium group. A potential vehicle for tumour targeting of antineoplastic triazenes.
    Baki AV; Vaughan K
    Carbohydr Res; 1982 Jul; 105(1):57-68. PubMed ID: 6180830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary metabolite of 1-(2,4,6-trichlorophenyl)-3,3-dimethyltriazene with an intact diazoamino structure.
    Kolar GF; Carubelli R
    Cancer Lett; 1979 Aug; 7(4):209-14. PubMed ID: 509404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cluster analysis in the development of structure-activity relations for antitumor triazenes.
    Dunn WJ; Greenberg MJ; Callejas SS
    J Med Chem; 1976 Nov; 19(11):1299-301. PubMed ID: 1003406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The formation and metabolism of N-hydroxymethyl compounds--I. The oxidative N-demethylation of N-dimethyl derivatives of arylamines, aryltriazenes, arylformamidines and arylureas including the herbicide monuron.
    Ross D; Farmer PB; Gescher A; Hickman JA; Threadgill MD
    Biochem Pharmacol; 1982 Nov; 31(22):3621-7. PubMed ID: 7181943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitumor activity of halogen-substituted 4-(3,3-dimethyl-1-triazeno)quinolines.
    Lin AJ; Loo TL
    J Med Chem; 1978 Mar; 21(3):268-72. PubMed ID: 628002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiproliferative activity of triazenoindazoles and triazenopyrazoles: a comparative study.
    Daidone G; Raffa D; Maggio B; Valeria Raimondi M; Plescia F; Schillaci D
    Eur J Med Chem; 2004 Mar; 39(3):219-24. PubMed ID: 15051169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.